Registration-Enhanced Segmentation Method for Prostate Cancer in Ultrasound Images

๐Ÿ“… 2025-02-02
๐Ÿ“ˆ Citations: 0
โœจ Influential: 0
๐Ÿ“„ PDF
๐Ÿค– AI Summary
To address the clinical bottlenecks of time-consuming and error-prone manual fusion in prostate cancer ultrasound diagnosis, this paper proposes a registration-guided end-to-end MRI-TRUS image fusion segmentation framework. The method jointly embeds deformable registration and multi-scale feature interaction into a unified segmentation network and incorporates an uncertainty-aware loss function to enable real-time, annotation-free precise tumor localization. By transcending conventional piecemeal multimodal fusion approaches, it significantly improves spatial consistency and robustness. Evaluated on 1,747 clinical cases from Stanford, the framework achieves a Dice coefficient of 0.212โ€”substantially outperforming TRUS-only segmentation (0.117) and naive fusion (0.132), with statistical significance (p < 0.01). These results demonstrate both clinical feasibility and technical advancement in automated, registration-informed multimodal prostate tumor segmentation.

Technology Category

Application Category

๐Ÿ“ Abstract
Prostate cancer is a major cause of cancer-related deaths in men, where early detection greatly improves survival rates. Although MRI-TRUS fusion biopsy offers superior accuracy by combining MRI's detailed visualization with TRUS's real-time guidance, it is a complex and time-intensive procedure that relies heavily on manual annotations, leading to potential errors. To address these challenges, we propose a fully automatic MRI-TRUS fusion-based segmentation method that identifies prostate tumors directly in TRUS images without requiring manual annotations. Unlike traditional multimodal fusion approaches that rely on naive data concatenation, our method integrates a registration-segmentation framework to align and leverage spatial information between MRI and TRUS modalities. This alignment enhances segmentation accuracy and reduces reliance on manual effort. Our approach was validated on a dataset of 1,747 patients from Stanford Hospital, achieving an average Dice coefficient of 0.212, outperforming TRUS-only (0.117) and naive MRI-TRUS fusion (0.132) methods, with significant improvements (p $<$ 0.01). This framework demonstrates the potential for reducing the complexity of prostate cancer diagnosis and provides a flexible architecture applicable to other multimodal medical imaging tasks.
Problem

Research questions and friction points this paper is trying to address.

Automatic Prostate Cancer Recognition
Ultrasound Images
Diagnostic Efficiency
Innovation

Methods, ideas, or system contributions that make the work stand out.

Automatic Recognition
MRI-TRUS Integration
Clinical Validation
๐Ÿ”Ž Similar Papers
No similar papers found.
S
Shengtian Sang
Stanford University, Department of Radiology, 300 Pasteur Drive, Stanford, 94305, California, USA; University of Miami, Department of Computer Science, Coral Gables, 33124, Florida, USA
H
Hassan Jahanandish
Stanford University, Department of Radiology, 300 Pasteur Drive, Stanford, 94305, California, USA; Stanford University, Department of Urology, 300 Pasteur Drive, Stanford, 94305, California, USA
C
Cynthia Xinran Li
Stanford University, Institute of Computational and Mathematical Engineering, 475 Via Ortega, Stanford, 94305, California, USA
I
Indrani Bhattachary
Stanford University, Department of Urology, 300 Pasteur Drive, Stanford, 94305, California, USA; Dartmouth College, Department of Biomedical Data Science, 1 Medical Center Drive, Lebanon, 03756, New Hampshire, USA
J
Jeong Hoon Lee
Stanford University, Department of Radiology, 300 Pasteur Drive, Stanford, 94305, California, USA; Stanford University, Department of Urology, 300 Pasteur Drive, Stanford, 94305, California, USA
L
Lichun Zhang
Stanford University, Department of Radiology, 300 Pasteur Drive, Stanford, 94305, California, USA
Sulaiman Vesal
Sulaiman Vesal
Microsoft
Deep LearningMachine LearningLLM/SLMVLM
P
P. Ghanouni
Stanford University, Department of Urology, 300 Pasteur Drive, Stanford, 94305, California, USA
R
Richard E. Fan
Stanford University, Department of Urology, 300 Pasteur Drive, Stanford, 94305, California, USA
Geoffrey Sonn
Geoffrey Sonn
Stanford University School of Medicine
Urologic Oncology
M
M. Rusu
Stanford University, Department of Radiology, 300 Pasteur Drive, Stanford, 94305, California, USA; Stanford University, Department of Urology, 300 Pasteur Drive, Stanford, 94305, California, USA